BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2800363
Number of visits today
651
Number of downloads
2054499
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Tombling BJ, Zhang Y, Huang YH, Craik DJ, Wang CK. The emerging landscape of peptide-based inhibitors of PCSK9. Atherosclerosis 2021;330:52-60. [PMID: 34246818 DOI: 10.1016/j.atherosclerosis.2021.06.903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ahamad S, Bhat SA. Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment. J Med Chem 2022;65:15513-39. [PMID: 36446632 DOI: 10.1021/acs.jmedchem.2c01290] [Reference Citation Analysis]
2 Doolan JA, Williams GT, Hilton KLF, Chaudhari R, Fossey JS, Goult BT, Hiscock JR. Advancements in antimicrobial nanoscale materials and self-assembling systems. Chem Soc Rev 2022;51:8696-755. [PMID: 36190355 DOI: 10.1039/d1cs00915j] [Reference Citation Analysis]
3 Chen R, Zhao H, Zhou J, Wang Y, Li J, Zhao X, Li N, Liu C, Zhou P, Chen Y, Song L, Yan H. Prognostic Impacts of LL-37 in Relation to Lipid Profiles of Patients with Myocardial Infarction: A Prospective Cohort Study. Biomolecules 2022;12. [PMID: 36291690 DOI: 10.3390/biom12101482] [Reference Citation Analysis]
4 Zhang Y, Wang L, Tombling BJ, Lammi C, Huang Y, Li Y, Bartolomei M, Hong B, Craik DJ, Wang CK. Improving Stability Enhances In Vivo Efficacy of a PCSK9 Inhibitory Peptide. J Am Chem Soc . [DOI: 10.1021/jacs.2c08029] [Reference Citation Analysis]
5 Salekeen R, Haider AN, Akhter F, Billah MM, Islam ME, Didarul Islam KM. Lipid oxidation in pathophysiology of atherosclerosis: Current understanding and therapeutic strategies. International Journal of Cardiology Cardiovascular Risk and Prevention 2022;14:200143. [DOI: 10.1016/j.ijcrp.2022.200143] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Hackam DG, Hegele RA. Lipid-Modifying Therapies and Stroke Prevention. Curr Neurol Neurosci Rep 2022. [PMID: 35554824 DOI: 10.1007/s11910-022-01197-4] [Reference Citation Analysis]
7 Seidah NG, Prat A. The multifaceted biology of PCSK9. Endocr Rev 2021:bnab035. [PMID: 34626468 DOI: 10.1210/endrev/bnab035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345